BRNS — Barinthus Biotherapeutics Share News
0.000.00%
Last trade - 00:00NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:13 PM
Brief: Vaccitech Announces Notification Of Milestone And Royalty Revenue Relating To Sales Of Vaxzevria
NASDAQ RESUMED AT 11:12 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:56 AM
Brief: Vaccitech Reports Full-Year 2021 Financial Results And Recent Corporate Developments
Brief: Cancer Research UK Says Dosed First Patient In Phase I/Iia Trial Of Lung Cancer Immunotherapy Vaccine
UCB remains Jefferies' biotech top pick, hikes Zealand Pharma to 'buy'
NASDAQ RESUMED AT 02:20 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:15 PM
Brief: Vaccitech Acquires Avidea Technologies To Expand Product Pipeline And Strengthen Scientific Leadership In Immunotherapies And Vaccines
Brief: Vaccitech Reports Promising Interim Efficacy Analysis In Phase 1B/2A Clinical Study In Chronic HBV
Brief: Vaccitech Announces HBV Infection Treatment Interim Data
Brief: Vaccitech Reports Third Quarter 2021 Financial Results And Recent Corporate Developments
Vaccitech PLC reports results for the quarter ended in June - Earnings Summary
Brief: Vaccitech Reports Q2 Loss Per Share Of $0.64
Brief: Arbutus Biopharma And Vaccitech Announce Clinical Trial Collaboration Agreement To Evaluate Rnai Therapeutic, AB-729, In Combination With Immunotherapeutic, Vtp-300, In Subjects With Chronic Hepatitis B Virus Infection
Media: Vaccitech chief confident of beating mRNA in cancer treatment - FT
Brief: Vaccitech Reports Q1 Loss Per Share Of $1.90
U.S. STOCKS ON THE MOVE-Vimeo, Moderna, Pieris Pharmaceuticals, Novan, Virgin Galactic